NCT05351762 2022-07-05Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCCXijing HospitalPhase 2 Unknown55 enrolled
NCT00357617 2010-12-24Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By SurgeryNational Cancer Institute (NCI)Phase 1/2 Unknown24 enrolled